UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032526
Receipt number R000037095
Scientific Title Clinical study for the safety and efficacy of the hydrogen breath test
Date of disclosure of the study information 2018/05/14
Last modified on 2023/05/14 16:58:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study for the safety and efficacy of the hydrogen breath test

Acronym

The safety and efficacy of the hydrogen breath test

Scientific Title

Clinical study for the safety and efficacy of the hydrogen breath test

Scientific Title:Acronym

The safety and efficacy of the hydrogen breath test

Region

Japan


Condition

Condition

Digestive disease, healthy adult

Classification by specialty

Gastroenterology Gastrointestinal surgery Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Confirmation of the safety and efficacy of the hydrogen breath test

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The concentration measurement of the breath hydrogen using Gastrolyser

Key secondary outcomes

Changes in the breath hydrogen concentration due to circadian rhythm, lactose consumption, hydrogen inhalation, platinum antitumor agent administration and surgical intervention.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Those who are informed to the fullest extent about the purposes and contents of the study, have the ability to give consent, volunteer for participation after having fully understood, and agree to participate in the study writing.

Key exclusion criteria

Patients who reject to participate in this study
Patients whom the investigator considers inappropriate for entry into the trial.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Teruo
Middle name
Last name Kiyama

Organization

TMG Asaka Medical Center

Division name

Department of Surgery

Zip code

351-0023

Address

1340-1 Mizonuma, Asaka, Saitama

TEL

048-466-2055

Email

kiyama@nms.ac.jp


Public contact

Name of contact person

1st name Teruo
Middle name
Last name Kiyama

Organization

TMG Asaka Medical Center

Division name

Department of Surgery

Zip code

351-0023

Address

1340-1 Mizonuma, Asaka, Saitama

TEL

048-466-2055

Homepage URL


Email

kiyama@nms.ac.jp


Sponsor or person

Institute

Department of Surgery
TMG Asaka Medical Center

Institute

Department

Personal name



Funding Source

Organization

Department of Surgery
TMG Asaka Medical Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

TMG Asaka Medical Center, Ethics committee

Address

1340-1 Mizonuma, Asaka, Saitama

Tel

048-466-2055

Email

h_haruta@tmg.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

TMGあさか医療センター(埼玉県)


Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

149

Results

Redox state was quantified using the breath hydrogen pressure in healthy Japanese subjects (n=149). The median pH2 increased from 4.89 to 5.05 after daily activities, which suggested approximately +5 mV oxidation. The breath pH2-scale may thus be a novel marker of the redox state in humans, which is relevant for many medical and research applications.

Results date posted

2021 Year 11 Month 10 Day

Results Delayed

Delay expected

Results Delay Reason

under submission

Date of the first journal publication of results


Baseline Characteristics

This study was conducted on a total of 149 healthy, non-obese Japanese subjects, comprising 98 women and 51 men, with an average age of 29.8 years.

Participant flow

Measurements were carried out using a portable, hand-held H2 monitor at 8 am as the study baseline. The subjects were then allowed to start their daily activities. Measurements were carried out again at noon (before lunch) to avoid the influence of eating and drinking on the breath test results.

Adverse events

none

Outcome measures

We tested the hypothesis that the oxidation-reduction potential (ORP) is proportional to the negative logarithm of the H2 partial pressure (pH2) in phosphate buffer solution (pH=7.1). To determine whether human redox state can be quantified, pH2 was measured by breath H2 partial pressure in healthy human subjects.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 03 Month 14 Day

Date of IRB

2018 Year 04 Month 01 Day

Anticipated trial start date

2018 Year 06 Month 01 Day

Last follow-up date

2018 Year 12 Month 01 Day

Date of closure to data entry

2019 Year 01 Month 31 Day

Date trial data considered complete

2019 Year 02 Month 01 Day

Date analysis concluded

2021 Year 06 Month 30 Day


Other

Other related information

nothing


Management information

Registered date

2018 Year 05 Month 09 Day

Last modified on

2023 Year 05 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037095


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name